Abstract
In a multicellular organism, cells communicate with each other mostly through the cell surface, which is represented by the plasma membrane with its lipids and proteins. A subset of the membrane proteins, i.e., receptors, are specialized to recognize and bind signalling molecules if arriving at sufficient concentrations at the cell surfaces. These signalling molecules, called receptor ligands, are either synthesized and secreted by other cells of the organism or taken up from the outside world. Ligands can be hormones, neurotransmitters, autacoids, growth factors, odorants, or physical signals, such as light. The binding of ligands to their cognate receptors leads to intracellular responses, e.g., changes in intracellular ion concentrations, de novo synthesis of proteins, or secretion of presynthesized proteins or transmitters. In many regulatory processes, the intracellular response is mediated by so-called second messengers, e.g., cyclic adenosine or guanosine monophosphate (cAMP or cGMP) or inositol 1,4,5-trisphosphate (IP3), which are generated upon receptor activation as a consequence of the ligand signalling. The extracellular signalling components or ligands are called first messengers, and the membrane structures leading to second messenger generation are generally covered by the terms receptors, signal transducers (G proteins), and effectors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Agrawal S (1996) Antisense therapeutics. In: Walker JM (ed) Methods in molecular medicine. Humana, Totowa, NJ
Albert PR, Morris SJ (1994) Antisense knockouts: molecular scalpels for the dissection of signal transduction. Trends Pharmacol Sci 15:250–254
Araki E, Lipes MA, Patti M-E, Brüning JC, Haag III B, Johnson RS, Kahn CR (1994) Alternative pathway of insulin signalling in mice with targeted disruption of IRS-1 gene. Nature 372:186–190
Baertschi AJ (1994) Antisense oligonucleotide strategies in physiology. Mol Cell Endocrinol 101: R15–R24
Baertschi AJ, Audigier Y, Lledo P-M, Israel J-M, Bockaert J, Vincent J-D (1992) Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectors. Mol Endocrinol 6:2257–2265
Baldwin JM (1994) Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol 6:180–190
Barton CM, Lemoine NR (1995) Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression. Br J Cancer 71:429–437
Bennett FC, Chiang M-Y, Chan H, Shoemaker JEE, Mirabelli CK (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 41:1023–1033
Birnbaumer L (1992) Receptor-to-effector signaling through G proteins: roles for βγ dimers as well as α subunits. Cell 71:1069–1072
Buckley NJ, French-Mullen J, Caulfield M (1995) Use of antisense oligonucleotides and monospecific antisera to inhibit G-protein gene expression in cultured neurons. Biochem Soc Trans 23:137–141
Burgess TL, Fisher EF, Ross SL, Gready JV, Qian Y-X, Bayewitch LA, Cohen AM, Herrera CJ, Hu SS-F, Kramer TB, Lott FD, Martin FH, Pierce GF, Simonet L, Farrell CF (1995) The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci USA 92:4051–4055
Campbell V, Berrow N, Dolphin AC (1993) GABAB receptor modulation of Ca2+ currents in rat sensory neurones by the G protein Go: antisense oligonucleotide studies. J Physiol (Lond) 470:1–11
Chang W-J, Ying Y-S, Rothberg KG, Hooper NM, Turner AJ, Gambiel HA, DeGunzburg J, Mumby SM, Gilman AG, Anderson RGW (1994) Purification and characterization of smooth muscle cell caveolae. J Cell Biol 126:127–138
Chen Y, Baez M, Yu L (1995) Functional coupling of the 5-HT2c serotonin receptor to G proteins in Xenopus oocytes. Neurosci Lett 179:100–102
Costa A-MN, Spence KT, Plata-Salamán CR, French-Mullen JMH (1995) Residual Ca2+ channel current modulation by megestrol acetate via a G-protein αs-subunit in rat hypothalamic neurones. J Physiol (Lond) 487:291–303
Crooke RS, Graham MJ, Cooke ME, Crooke ST (1995) In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides. J Pharmacol Exp Ther 275:462–473
Crooke ST (1993) Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J 7:533–539
Crooke ST (1995) Therapeutic applications of oligonucleotides. Medical intelligence unit. Landes, Austin, Texas, USA
Crooke ST, Bennett CF (1996) Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol 36:107–129
Degtiar VE, Wittig B, Schultz G, Kalkbrenner F (1996) A specific heterotrimer couples somatostatin receptors to voltage-gated calcium channels in RINm5F cells. FEBS Lett 380:137–141
Degtiar VE, Wittig B, Schultz G, Kalkbrenner F (1997) Microinjection of antisense oligonucleotides and electrophysiological recording of whole cell currents as tool to identify specific G-protein subtypes coupling hormone receptors to voltage-gated calcium channels. In: Bar-Sagi D (ed) Transmembrane signaling protocols. Methods in molecular biology, vol 84. Humana, Totowa, NJ (in press)
De Mazancourt P, Goldsmith PK, Weinstein LS (1994) Inhibition of adenylate cyclase activity by galanin in rat insulinoma cells is mediated by the G-protein Gi3. Biochem J 303:369–375
Dippel E, Kalkbrenner F, Wittig B, Schultz G (1996) The muscarinic ml receptor couples to specific G-protein heterotrimers to increase the cytosolic calcium concentration. Proc Natl Acad Sci USA 93:1391–1396
French-Mullen JMH, Plata-Salamán CR, Buckley NJ, Danks P (1994) Muscarinic modulation by a G-protein alpha-subunit of delayed rectifier K+ current in rat ventromedial hypothalamic neurones. J Physiol (Lond) 474:21–26
Goetzl EJ, Shames RS, Yang J, Birke FW, Liu YF Albert PR, An S (1994) Inhibition of human HL-60 cell responses to chemotactic factors by antisense messenger RNA depletion of G proteins. J Biol Chem 269:809–812
Gollasch M, Kleuss C, Hescheler J, Wittig B, Schultz G (1993) Gi2 and protein kinase C are required for thyrotropin-releasing hormone-induced stimulation of voltage-dependent Ca2+ channels in rat pituitary GH3 cells. Proc Natl Acad Sci USA 90:6265–6269
Gudermann T, Nürnberg B, Schultz G (1995) Receptors and G proteins as primary components of transmembrane signal transduction. 1. G-protein-coupled receptors: structure and function. J Mol Med 73:51–63
Gudermann T, Kalkbrenner F, Schultz G (1996) Diversity and selectivity of receptor-G protein interaction. Annu Rev Pharmacol Toxicol 36:429–459
Guvakova MA, Yakubov LA, Vlodaysky I, Tonkinson JL, Stein CA (1995) Phosphorothioate oligodeoxynucleotides bind to basic fibroblast factor, inhibits its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem 270:2620–2627
Hansen CA, Schoering AG, Carey DJ, Robishaw JD (1994) Localisation of a heterotrimeric G protein γsubunit to focal adhesions and associated stress fibers. J Cell Biol 126:811–819
Hélène C, Toulmé J-J (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1049:99–125
Jones SV, Choi OH, Beaven MA (1991) Carbachol induces secretion in a mast cell line (RBL-2H3) transfected with the ml muscarinic receptor. FEBS Lett 289:47–50
Kalkbrenner F, Degtiar VE, Schenker M, Brendel S, Zobel A, Hescheler J, Wittig B, Schultz G (1995) Subunit composition of Go proteins functionally coupling galanin receptors to voltage-gated calcium channels. EMBO J 14:4728–4737
Kalkbrenner F, Dippel E, Wittig B, Schultz G (1996) Specificity of the receptor—Gprotein interaction: using antisense techniques to identify the function of G protein-subunits. Biochim Biophys Acta 1314:125–139
Kalkbrenner F, Dippel E, Schroff M, Wittig B, Schultz G (1997) Intranuclear micro-injection and ballistomagnetic transfer of antisense oligonucleotides as tools to determine receptor interaction of G-protein heterotrimers causing phospholipase C-β activation. In Challis RAJ (ed) Receptor signal transduction protocols. Methods in molecular biology, vol 83. Humana, Totowa, NJ, pp 203–216
Kasahara J, Sugiyama H (1994) Inositol phospholipid metabolism in Xenopus oocytes mediated by endogenous Go and Gi protein. FEBS Lett 355:41–44
Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G, Wittig B (1991) Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 353:43–48
Kleuss C, Scherübel H, Hescheler J, Schultz G, Wittig B (1992) Different β-subunits determine G-protein interaction with transmembrane receptors. Nature 358:424–426
Kleuss C, Scherübel H, Hescheler J, Schultz G, Wittig B (1993) Selectivity in signal transduction determined by γ subunits of heterotrimeric G proteins. Science 259:832–834
Kleuss C, Schultz G, Wittig B (1994) Microinjection of antisense oligonucleotides to assess G-protein subunit function. Methods Enzymol 237:345–355
Kwon G, Axelrod D, Neubig RR (1994) Lateral mobility of tetramethylrhodamine (TMR) labelled G protein α and βγsubunits in NG 108–15 cells. Cell Signal 6:663–679
Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270:15693–15701
Li S, Song K, Lisanti MP (1996) Expression and characterization of recombinant caveolin. J Biol Chem 271:568–573
Lisanti MP, Scherer PE, Vidugiriene J, Tang ZL, Hermanowski-Vosatka A, Tu Y-H, Cook RF, Sargiacomo M (1994) Characterization of caveolin-rich membrane domains isolated from an endothelin-rich source: implications for human disease. J Cell Biol 126:111–126
Liu YF, Jakobs KH, Rasenick MM, Albert PR (1994) G protein specificity in receptor-effector coupling. J Biol Chem 269:13880–13886
Loke SL, Stein CA, Zhang XH, Mori K, Nakanishi M, Subashinghe C, Cohen JS, Neckers LM (1989) Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 86:3474–3478
Macrez-Leprêtre N, Kalkbrenner F, Schultz G, Mironneau J (1997a) Distinct functions of Gq and Gll proteins in coupling α1A -adrenoceptors to Ca2+ release and Ca2+ entry in rat portal vein myocyte. J Biol Chem 272:5261–5268
Macrez-Leprêtre N, Kalkbrenner F, Morel J-L, Schultz G, Mironneau J (1997b) G protein heterotrimer Gα13β1γ3 couples angiotensin AT1A receptor to increase in cytosolic Ca2+ in rat portal vein myocytes. J Biol Chem 272:10095–10102
Meissner JD, Brown GA, Mueller WH, Scheibe RJ (1996) Retinoic acid-mediated decrease of Gas protein expression: involvement of Gas in the differentiation of HL-60 myeloid cells. Exp Cell Res 225:112–121
Milligan G (1995) Signal sorting by G-protein-linked receptors. Adv Pharmacol 32:129
Milligan JF, Matteucci MD, Martin JC (1993) Current concepts in antisense drug design. J Med Chem 36:1923–1937
Mortensen RM, Seidman JG (1994) Inactivation of G-protein genes: double knockout in cell lines. Methods Enzymol 237:356–386
Moxam CM, Malbon CC (1996) Insulin action impaired by deficiency of the G-protein subunit Giα2. Nature 379:840–844
Moxam CM, Hod Y, Malbon CC (1993a) Induction of Gαi2-specific antisense RNA in vivo inhibits neonatal growth. Science 260:991–995
Moxam CM, Hod Y, Malbon CC (1993b) Giα2 mediates the inhibitory regulation of adenylylcyclase in vivo: analysis in transgenic mice with Giα2 suppressed by inducible antisense RNA. Dev Genet 14:266–273
Neer EJ (1995) Heterotrimeric G proteins: organizer of transmembrane signals. Cell 80:249–257
Neubig RR (1994) Membrane organization in G-protein mechanisms. FASEB J 8:939–946
Nürnberg B, Gudermann T, Schultz G (1995) Receptors and G proteins as primary components of transmembrane signal transduction, part 2. G proteins: structure and function. J Mol Med 73:123–132, correction: 73:379
Offermanns S, Schultz G (1994) Complex information processing by the transmembrane signaling system involving G proteins. Naunyn Schmiedebergs Arch Pharmacol 350:329–338
Offermanns S, Laugwitz K-L, Spicher K, Schultz G (1994) G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 31:504–508
Offermanns S, Mancino V, Revel, J-P, Simon MI (1997) Vascular system defects and impaired cell chemokinesis as a result of Gα13 deficiency. Science 275:533–536
Pasternak GW, Standifer KM (1995) Map** of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol Sci 16:344–350
Paulssen RH, Paulssen EJ, Gautvik KM, Gordeladze JO (1992) The thyroliberin receptor interacts directly with a stimulatory guanine-nucleotide-binding protein in the activation of adenylyl cyclase in GH3 rat pituitary tumour cells. Eur J Biochem 204:413–418
Plata-Salamán CR, Wilson CD, Sonti G, Borkowski JP, French-Mullen JM (1995) Antisense oligodeoxynucleotides to G-protein α-subunit subclasses identify a transductional requirement for the modulation of normal feeding dependent on GαoA subunit. Brain Res Mol Brain Res 33:72–78
Quick MW, Simon MI, Davidson N, Lester HA, Aragay A (1994) Differential coupling of G protein α subunits to seven-helix receptors expressed in Xenopus oocytes. J Biol Chem 269:30164–30172
Raffa RB (1996) In vivo antisense strategy for the study of second-messengers: application to G-proteins. In: Raffa RB, Porecca F (eds) Antisense strategies for the study of receptor mechanisms. Landes, Austin, Texas, USA, pp 53–69
Raffa RB, Porecca F (1996) Antisense strategies for the study of receptor mechanisms. Landes, Austin, Texas, USA
Raffa RB, Martinez RP, Connelly CD (1994) G-protein antisense oligodeoxyribonucleotides and µ-opioid supraspinal antinociception. Eur J Pharmacol 258:R5–R7
Raffa RB, Goode TL, Martinez RP, Jacoby HI (1996a) A Gi2a antisense oligonucleotide differentiates morphine antinociception, constipation and acute dependence in mice. Life Sci 58:73–76
Raffa RB, Conelly CD, Chambers JR, Stone DJ (1996b) α-subunits G-protein antisense oligonucleotide effects on supraspinal (i.c.v.) α2-adrenoceptor antinociception in mice. Life Sci 58:77–80
Rossi GC, Standifer KM, Pasternak GW (1995) Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats. Neurosci Lett 198:99–102
Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivansan Y, Brabet P, Boulay G, Bradley A, Birnbaumer L (1995) Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice. Nature Genet 10:143–150
Rudolph U, Spicher K, Birnbaumer L (1996) Adenylyl cyclase inhibition and altered G protein subunit expression and ADP-ribosylation patterns in tissues and cells from Gi2α -/- mice. Proc Natl Acad Sci USA 93:3209–3214
Sargiacomo M, Sudol M, Tang ZL, Lisanti MP (1993) Signal transduction molecules and glycosyl-phosphatidylinositol-linked proteins form caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122:789–807
Sánchez-Blázquez P, García-España A, Garzón J (1995) In vivo injection of antisense oligodeoxynucleotides to Gα subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J Pharmacol Exp Ther 275:1590–1596
Shapira H, Way J, Lipinsky D, Oron Y, Battey JF (1994) Neuromedin B receptor, expressed in Xenopus laevis oocytes, selectively couples to Gαq and not Gαll. FEBS Lett 348:89–92
Schreibmayer W, Dessauer CW, Vorobiov D, Gilman AG, Lester HA, Davidson N, Dascal N (1996) Inhibition of an inwardly rectifying K+ channel by G-protein α-subunits. Nature 380:624–627
Schlingensiepen KH, Schlingensiepen R, Brysch W (1996) Antisense oligodeoxynucleotides: from technology to therapy. Blackwell International/Blackwell Wissenschaft, Berlin
Simon MI, Strathmann MP, Gautam N (1991) Diversity of G proteins in signal transduction. Science 232:802–808
Srinivasan SK, Tewary HK, Iversen PL (1995) Characterization of binding sites, extent of binding, and drug interaction of oligonucleotides with albumin. Antisense Res Dev 5:131–139
Standifer KM, Rossi GC, Pasternak GW (1996) Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein α subunits. Mol Pharmacol 50:293–298
Stehno-Bittel L, Krapivinsky G, Krapivinsky L, Perez-Terzic C, Clapham D (1995) The G protein βγ subunit transduces the muscarinic receptor signal for Ca2+ release in Xenopus oocytes. J Biol Chem 270:30068–30074
Stein CA, Cheng Y-C (1993) Antisense oligonucleotides as therapeutic agents — is the bullet really magical? Science 261:1004–1012
Strader CD, Fong TM, Tota MR, Underwood D, Dixon RAF (1994) Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101–132
Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182–186
Tang T, Kiang, JG, Côte TE, Cox BM (1995) Antisense oligodeoxynucleotide to the Gi2 protein α subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8–47 neuroblastoma x dorsal root ganglion hybrid cells. Mol Pharmacol 48:189–193
Voisin T, Lorinet A-M, Maoret J-J, Couvineau A, Laburthe M (1996a) Gαi RNA antisense expression demonstrates the exclusive coupling of peptide YY receptors to Gi2 proteins in renal proximal tubule cells. J Biol Chem 271:574–580
Voisin T, Lorinet A-M, Laburthe M (1996a) Partial knockdown of Gαi2 protein is sufficient to abolish the coupling of PYY receptors to biological response in renal proximal tubule cells. Biochem Biophys Res Commun 225:16–21
Wahlestedt C (1994) Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol Sci 15:42–46
Wahlestedt C (1996) Antisense “knockdown” strategies in neurotransmitter receptor research. In: Raffa RB, Porecca F (eds) Antisense strategies for the study of receptor mechanisms. Landes, Austin, Texas, USA, pp 1–10
Wang H-Y, Watkins DC, Malbon CC (1992) Antisense oligodeoxynucleotides to Gs protein α-subunit sequence accelerate differentiation of fibroblasts to adipocytes. Nature 358:334–337
Wang H-Y, Johnson GL, Liu X, Malbon CC (1996) Repression of adipogenesis by adenylyl cyclase stimulatory G-protein α subunit is expressed within region 146220. J Biol Chem 271:22022–22029
Watkins DC, Johnson GL, Malbon CC (1992) Regulation of differentiation of teratocarcinoma cells into primitive endoderm by Gαi2 Science 258:1373–1375
Watkins DC, Moxham CM, Morris AJ, Malbon CC (1994) Suppression of Giα2 en-hances phospholipase C signalling. Biochem J 299:593–596
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kalkbrenner, F., Wittig, B., Schultz, G. (1998). Inhibition of G Proteins by Antisense Drugs. In: Crooke, S.T. (eds) Antisense Research and Application. Handbook of Experimental Pharmacology, vol 131. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58785-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-58785-6_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63730-8
Online ISBN: 978-3-642-58785-6
eBook Packages: Springer Book Archive